Management of Syphilis with Rising Titers After Treatment

Assessment of Treatment Failure

The Centers for Disease Control and Prevention (CDC) guidelines consider a greater than fourfold increase in titers (from 1:64 to 1:132) as serological treatment failure 1, 2
A fourfold increase in titers after treatment suggests either reinfection or treatment failure, both requiring intervention 3
When titers increase fourfold after initial therapy, a CSF examination is mandatory to rule out neurosyphilis 2, 3

The CDC recommends performing CSF examination immediately to evaluate for neurosyphilis, looking for CSF abnormalities such as elevated protein, pleocytosis, or positive VDRL test 1, 2, 3
Clinical evaluation for signs/symptoms of neurologic involvement, ophthalmic manifestations, or evidence of tertiary syphilis is necessary 2
Retreatment regardless of CSF results is recommended, with Benzathine penicillin G 7.2 million units total for patients without neurosyphilis 1, 2, 4
For patients with neurosyphilis, the CDC recommends following neurosyphilis treatment protocol (typically aqueous crystalline penicillin G) 2

The CDC recommends repeat quantitative nontreponemal serologic tests at 6, 12, and 24 months after retreatment 2, 3
Expect at least a fourfold decline in titers within 12-24 months after retreatment 2
If titers fail to decline appropriately after retreatment, consider additional CSF examination 2

The CDC considers a significant rise in titer (from 1:64 to 1:132) concerning and requiring immediate intervention, as it exceeds the fourfold increase threshold that defines treatment failure 1, 2
HIV testing should be performed if not already done, as HIV status can affect syphilis treatment response 3